AvidBiotics Corp. is a biotherapeutics company deploying two proprietary, biotechnology-based platforms for multiple applications in life sciences. We are developing further Nature's proven successes. With virtual operations commencing in 2005, the company initiated its own lab operation in 2006.
Our first application is the development of protein products for the treatment of specific bacterial diseases of humans, with particular emphasis on antibiotic-resistant bacteria.
Cambrios is currently focused on the development of electronic materials for the display industry. Our proprietary nanostructured materials can be deposited using existing production equipment to achieve enhanced performance of display devices and components at lower manufacturing cost. The company's first product, a directly patternable, wet-processable transparent conductive film, is poised to replace the industry standard sputtered indium tin oxide (ITO). Subsequent products will leverage this technology to produce other functional film for display and thin films applications.
TCHO is a new kind of chocolate company for a new generation of chocolate enthusiasts. TCHO is where technology meets chocolate; where Silicon Valley start-up meets San Francisco food culture.
TCHO is obsessively good dark chocolate.
TCHO is direct, transparent connection between the farmers and the consumers, from the pod to the palate, from high concept to sensual experience.
TCHO is an innovative method for you to discover the chocolate you like best.
Viamet Pharmaceuticals® is and exciting, new pharmaceutical company that discovers and develops metal-targeted therapeutics. Viamet's scientific foundation is based on a growing understanding as to the critical role of metals such as zinc, iron and copper in the activity of key biological targets important in inflammation and infectious disease.
Hatteras Venture Partners
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies.
New Cross Technologies, Inc.
NewCross Technologies delivers industry-leading hosted VolP solutions to service providers. With superior technology and adaptability, we enable our customers to transform and enhance their businesses with outsourced VoIP solutions. NewCross enables you to focus on your own customers and business, while leaving the VolP infrastructure and delivery to us. NewCross helps drive growth and value to both service provider and reseller businesses.
Novocell, Inc. is a stem cell engineering company dedicated to creating, delivering and commercializing cell and drug therapies to treat diabetes and other chronic diseases. Novocell uses its proprietary cell encapsulation technology and expertise in cell implantation to develop a renewable source of specialized cells for treatment of cellular diseases.